In addition, they also reported both a TAAR1-downregulation of in sarcoma, renal, cervical, liver, kidney, pancreas, prostate, pituitary, and uterine cancers, and an upregulated expression of TAAR1 in esophageal, stomach and lung cancers [116]. This evidence concerns the gene TAAR1 and uterine cancer.